Shukra Pharmaceuticals

Closure of Trading Window

20 Mar, 2026 | 12:58pm • Source: BSE

Independent Directors Meeting

16 Mar, 2026 | 01:33pm • Source: BSE

Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/03/2026 ,inter alia, to consider and...

06 Mar, 2026 | 04:44pm • Source: BSE

Newspaper publication of Standalone and Consolidated Un-audited Financial Results for Quarter and Nine month ended 31st December 2025

05 Feb, 2026 | 02:13pm • Source: BSE

Unaudited Financial Results for the quarter ended December 2025

04 Feb, 2026 | 04:27pm • Source: BSE

Considered and approved Un-audited Financial results of the Company for the Third Quarter and Nine Months ended December 31, 2025.

04 Feb, 2026 | 04:07pm • Source: BSE

Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 ,inter alia, to consider and...

30 Jan, 2026 | 02:58pm • Source: BSE

Certificate under Regulation 74(5) of SEBI ( Depositories and Participants ) for the quarter ended December 31, 2025.

07 Jan, 2026 | 01:55pm • Source: BSE

As attached

05 Jan, 2026 | 07:41pm • Source: BSE

Intimation pertaining to Memorandum of Understanding ("MoU") with Borns Medical Robotics Inc., USA.

05 Jan, 2026 | 03:13pm • Source: BSE

Intimation for closure of trading window

23 Dec, 2025 | 02:17pm • Source: BSE

Sell the Laparoscopic Sets and accessories in the Government market of Gujarat.

22 Dec, 2025 | 12:20pm • Source: BSE

Advertisement in Newspaper of Postal Ballot notice.

05 Dec, 2025 | 11:19am • Source: BSE

As attached

29 Nov, 2025 | 07:03pm • Source: BSE

Regulation 30 of the Securities and Exchange Board of India ( Listing Obligation and Disclosure Requirement ) Regulation, 2015

29 Nov, 2025 | 06:48pm • Source: BSE

Regulation 30 the Securities and Exchange Board of India ( Listing Obligation and Disclosure Requirement ) Regulation, 2015.

29 Nov, 2025 | 06:43pm • Source: BSE

Publication of Standalone Un-Audited Financial Results for Second Quarter and Half Year Ended on September 30, 2025

14 Nov, 2025 | 06:40pm • Source: BSE

Incorporation of subsidiary company.

10 Nov, 2025 | 03:04pm • Source: BSE

As attached.

01 Nov, 2025 | 06:49pm • Source: BSE

Proceeding of EOGM of the company.

01 Nov, 2025 | 03:54pm • Source: BSE